Azithromycin augments rhinovirus-induced IFNβ via cytosolic MDA5 in experimental models of asthma exacerbation.

Oncotarget · 2017 · PMC5458233 · PMID 28415826

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A clinical trial aiming at reducing viral-induced asthma exacerbations using exogenous IFNβ therapy showed a trend towards reducing viral load [ 11 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.